Clinicopathologic analysis of uterine sarcomas from a single institution in the Canary Islands

International Journal of Gynecology and Obstetrics

Volumn 107, Issue 1, 2009, Pages 44-49

  Benito, Virginia ^a   Lubrano, Amina ^a   Arencibia, Octavio ^a   Andújar, Miguel ^a   Álvarez, Eva ^a   Medina, Norberto ^a   Falcón, Juan Miguel ^a   Falcón, Orlando ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

Author keywords

Adenosarcoma; Endometrial stromal sarcoma; Leiomyosarcoma; Malignant mixed m llerian tumors; Uterine sarcoma

Indexed keywords

ADENOSARCOMA; ADULT; ARTICLE; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; ENDOMETRIUM SARCOMA; FEMALE; HISTOPATHOLOGY; HUMAN; KAPLAN MEIER METHOD; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; MIXED MULLERIAN TUMOR; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PARITY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SURGICAL TECHNIQUE; SURVIVAL RATE; TUMOR CLASSIFICATION; TUMOR VOLUME; UTERUS SARCOMA;

EID: 70249119959     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2009.05.020     Document Type: Article

References (25)

1. Harlow B.L., Weiss N.S., and Lofton S. The epidemiology of sarcomas of the uterus. J Natl Cancer Inst Mar 76 3 (1986) 399-402
2. In: Tavassoli F.A., and Devilee P. (Eds). Pathology and Genetics of Tumors of the Breast and Female Genital Organs. World Health Organization Classification of Tumors (2003), IARC Press, Lyon, France
3. Sleijfer S., Seynaeve C., and Verweij. Gynaecological sarcomas. Curr Opin Oncol 19 5 (2007) 492-496
4. González-Bosquet E., Martínez-Palones J.M., González-Bosquet J., García Jiménez A., and Xercavins J. Uterine sarcoma: a clinicopathological study of 93 cases. Eur J Gynaecol Oncol 18 3 (1997) 192-195
5. Prat J. FIGO staging for uterine sarcomas. Int J Gynecol Obstet 104 3 (2009) 177-178
6. Oláh K.S., Gee H., Blunt S., Dunn J.A., Kelly K., and Chan K.K. Retrospective analysis of 318 cases of uterine sarcoma. Eur J Cancer 27 9 (1991) 1095-1099
7. Nordal R.R., and Thoresen S.O. Uterine sarcomas in Norway 1956-1992: incidence, survival and mortality. Eur J Cancer 33 6 (May 1997) 907-911
8. El Husseiny G., Al Bareedy N., Mourad W.A., Mohamed G., Shoukri M., Subhi J., et al. Prognostic factors and treatment modalities in uterine sarcoma. Am J Clin Oncol 25 3 (2002) 256-260
9. Chauveinc L., Deniaud E., Plancher C., Sastre X., Amsani F., Rochefordiere A., et al. Uterine sarcomas: The Curie Institut experience. Prognosis factors and adjuvant treatments. Gynecol Oncol 72 2 (1999) 232-237
10. Pautier P., Genestie C., Rey A., Morice P., Roche B., Lhommé C., et al. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma. Cancer 88 6 (2000) 1425-1431
11. Benoit L., Arnould L., Cheynel N., Goui S., Collin F., Fraisse J., et al. The role of surgery and treatment trends in uterine sarcoma. Euro J Surg Oncol 31 4 (2005) 434-442
12. Kokawa K., Nishiyama K., Ikeuchi M., Ihara Y., Akamatsu N., Enomoto T., et al. Clinical outcomes of uterine sarcomas: results from 14 years worth of experience in the Kinki district in Japan (1990-2003). Int J Gynecol Cancer 16 3 (May-Jun 2006) 1358-1363
13. Yalman D., Ozsaran Z., Baltalarli B., Demir O., Ozdemir N., and Aras A. Results of postoperative radiotherapy in the treatment of uterine sarcomas: a retrospective analysis of 46 patients. Eur J Gynaecol Oncol 29 1 (2008) 46-51
14. Tsikouras P., Liberis V., Galazios G., Savidis A., Grapsa A., Grapsas X., et al. Uterine sarcoma: a report of 57 cases over a 16-year period analysis. Eur J Gynaecol Oncol 29 2 (2008) 129-134
15. Koivisto-Korander R., Butzow R., Koivisto A.M., and Leminen A. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001. Gynecol Oncol 111 1 (2008) 74-81
16. Denschlag D., Masoud I., Stanimir G., and Gilbert L. Prognostic factors and outcome in women with uterine sarcoma. Eur J Surg Oncol 33 1 (Feb 2007) 91-95
17. Callister M., Ramondetta L.M., Jhingran A., Burke T.W., and Eifel P.J. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors and treatment outcome. Int J Radiation Oncol Biol Phys 58 3 (2004) 786-796
18. Schwartz S.M., and Thomas D.B. A case-control study of risk factors for sarcomas of the uterus. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives. Cancer 64 12 (1989) 2487-2492
19. Marth C., Windbichler G., Petru E., Dirschlmayer W., Obermair A., Czerwenka K., et al. Parity as an independent prognostic factor in malignant mixed mesodermal tumors of the endometrium. Gynecol Oncol 64 1 (1997) 121-125
20. Huang G.S., Chiu L.G., Gebb J.S., Gunter M.J., Sukumvanich P., Goldberg G.L., and Einstein M.H. Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcoma. Gynecol Oncol 107 3 (2007) 513-517
21. Gadducci A., Cosio S., Romanini A., and Genazzani A.R. The management of patients with uterine sarcoma: a debated clinical challenge. Crit Rev Oncol Hematol 65 2 (2008) 129-142
22. Yamada S.D., Burger R.A., Brewster W.R., Anton D., Kohler M.F., and Monk B.J. Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus. Cancer 88 12 (2000) 2782-2786
23. Hornback N.B., Omura G., and Major F.J. Observations on the use of adjuvant radiation therapy in patients with stage I and II uterine sarcoma. Int J Radiat Oncol Biol Phys 12 12 (1986) 2127-2130
24. Livi L., Paiar F., Shah N., Blake P., Villanucci A., Amunni G., et al. Uterine sarcoma: twenty-seven years of experience. Int J Radiat Oncol Biol Phys 57 5 (2003) 1366-1373
25. Wolfson A., Brady M., Rocereto T., Mannel R., Lee Y.C., and Futoran R. A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus. Gynecol Oncol 107 2 (2007) 177-185